Torfp h - title: "pharmacokinetic studies with selected anticancer compounds in NSG mice" period of performance" 09/13/2019 - 09/12/2024
Ended Awarded Last action
- Contract number
- 75N91019F00129
- Awardee
-
Mayo Clinic UEI Y2K4F9RPRRG7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $174,696
Award facts
- Opportunity
-
- N02CM6700011 Solicitation number
- Preclinical Pharmacokinetic and Pharmacology Evaluations of Agents Being Developed for Cancer Patients Award Notice · Posted Feb 5, 2016
- Preclinical Pharmacokinetic and Pharmacological Studies Being Developed for Cancer Patients Award Notice · Posted Oct 6, 2015
- Contract value 80% obligated
-
- $174,696.00 Current, with exercised options
- $218,370.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rochester, MN 55905, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $21,837 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $21,837 | |
| Exercise an Option | $43,674 | |
| Exercise an Option | $65,511 | |
| Original award | $21,837 |
About this award
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $218,370.00 firm fixed-price delivery order contract to Mayo Clinic, a large non-profit academic medical center, for "Pharmacokinetic Studies with Selected Anticancer Compounds in NSG Mice." The period of performance is September 13, 2019 through September 12, 2024. This delivery order is issued under the Pharmacokinetic and Pharmacology Evaluations for Cancer Patients indefinite delivery/indefinite quantity (IDIQ) contract vehicle held by Mayo Clinic, which has a potential value of $9.9 million. Mayo Clinic provides a range of research and development services to support the National Cancer Institute's Experimental Therapeutics program and the development of new cancer treatments.
Quick answers
Who was awarded contract 75N91019F00129?
75N91019F00129 was awarded to Mayo Clinic by National Cancer Institute (National Institutes of Health) on September 13, 2019.
How much is contract 75N91019F00129 worth?
The government has obligated $174,696 on 75N91019F00129. Its potential value, with all options, is $218,370.
Is contract 75N91019F00129 an order under another contract?
Yes. 75N91019F00129 is a delivery order under HHSN261201600024I, an indefinite delivery contract, on Pharmacokinetic and Pharmacology Evaluations for Cancer Patients.
Was contract 75N91019F00129 competed?
The extent of competition for 75N91019F00129 was full and open competition. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award